Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trialsПодробнее

Johnson & Johnson Announces Single-Shot COVID-19 Vaccine | TODAYПодробнее

Johnson & Johnson one dose vaccine sees immune response in early trialsПодробнее

Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune ResponseПодробнее

Johnson & Johnson completes second phase trial of COVID-19 vaccine that requires one doseПодробнее

Johnson and Johnson vaccine shows promise in trialsПодробнее

Johnson and Johnson says 1-shot vaccine shows promising results in early trial | WNTПодробнее

Johnson & Johnson vaccine shows promise against Delta variant, plus COVID-19 back-to-school concernsПодробнее

Johnson & Johnson COVID-19 Vaccine Ships Out, Shows Promise Against Variant StrainsПодробнее

Johnson & Johnson's single-dose COVID-19 vaccine shows promising results in early trialsПодробнее

Moderna’s COVID Vaccine Shows Promise in Early Trial: StudyПодробнее

Johnson & Johnson in Phase 3 of one-dose vaccine trialПодробнее

COVID-19: Johnson & Johnson's single-shot vaccine 85% effective against most severe symptomsПодробнее

Coronavirus: Canada approves Johnson & Johnson’s 1-shot COVID-19 vaccine | FULLПодробнее

Johnson & Johnson single-dose COVID-19 vaccine on trialПодробнее

Covid-19 Vaccines: J&J Vaccine Shows PromiseПодробнее

Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, PfizerПодробнее

Vaccines 101: All about Phase 3 COVID-19 Vaccine Clinical Trials | Johnson & JohnsonПодробнее

Johnson & Johnson COVID-19 vaccine offers protection with just 1 shot | GMAПодробнее

Johnson & Johnson 1-shot vaccine approved | WNTПодробнее

J&J reports positive phase 1/2 Covid-19 vaccine trial resultsПодробнее